⌘K

Login Start Free

FIBROGEN INC·4

May 17, 4:49 PM ET

Rosenkranz Roberto Pedro 4

4 · FIBROGEN INC · Filed May 17, 2019

Insider Transaction Report

Form 4

Period: 2019-05-15

FIBROGEN INCFGEN

Rosenkranz Roberto Pedro

Director

Transactions

Exercise/Conversion
Common Stock
2019-05-15$18.34/sh+12,000$220,080→ 62,700 total
Exercise/Conversion
Common Stock
2019-05-15$9.78/sh+6,000$58,650→ 38,700 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-05-15−6,000→ 0 total
Exercise: $9.78Exp: 2023-04-17→ Common Stock (6,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-05-15−12,000→ 0 total
Exercise: $18.34Exp: 2025-06-03→ Common Stock (12,000 underlying)
Exercise/Conversion
Common Stock
2019-05-15$18.00/sh+12,000$216,000→ 50,700 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-05-15−12,000→ 0 total
Exercise: $18.00Exp: 2024-11-13→ Common Stock (12,000 underlying)

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION